Nuveen Asset Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $714K | Hold |
102,835
| – | – | ﹤0.01% | 2848 |
|
|
2024
Q3 | $545K | Buy |
102,835
+13,739
| +15% | +$72.8K | ﹤0.01% | 2986 |
|
|
2024
Q2 | $333K | Hold |
89,096
| – | – | ﹤0.01% | 3122 |
|
|
2024
Q1 | $628K | Hold |
89,096
| – | – | ﹤0.01% | 2893 |
|
|
2023
Q4 | $503K | Sell |
89,096
-64,747
| -42% | -$366K | ﹤0.01% | 3001 |
|
|
2023
Q3 | $737K | Buy |
153,843
+12,815
| +9% | +$61.4K | ﹤0.01% | 2699 |
|
|
2023
Q2 | $966K | Buy |
141,028
+29,379
| +26% | +$201K | ﹤0.01% | 2668 |
|
|
2023
Q1 | $870K | Sell |
111,649
-7,149
| -6% | -$55.7K | ﹤0.01% | 2656 |
|
|
2022
Q4 | $905K | Sell |
118,798
-13,849
| -10% | -$106K | ﹤0.01% | 2720 |
|
|
2022
Q3 | $1.08M | Sell |
132,647
-2,128
| -2% | -$17.4K | ﹤0.01% | 2721 |
|
|
2022
Q2 | $1.3M | Buy |
134,775
+70,891
| +111% | +$685K | ﹤0.01% | 2673 |
|
|
2022
Q1 | $802K | Buy |
63,884
+38,595
| +153% | +$485K | ﹤0.01% | 2883 |
|
|
2021
Q4 | $444K | Buy |
25,289
+8,535
| +51% | +$150K | ﹤0.01% | 3099 |
|
|
2021
Q3 | $373K | Buy |
+16,754
| New | +$373K | ﹤0.01% | 3221 |
|